ConductScience.org, home

Library / Genes

CAMK2G: calcium/calmodulin dependent protein kinase II gamma

1 protein, 13 patents, 0 drugs, 0 trials, 7,392 NIH grants and 11,344 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolCAMK2GHGNC
Namecalcium/calmodulin dependent protein kinase II gammaHGNC
NCBI Gene ID818NCBI Gene
HGNC IDHGNC:1463HGNC
EnsemblENSG00000148660NCBI Gene
AliasesCAMK, CAMK-II, CAMKG, MRD59NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q13555Calcium/calmodulin-dependent protein kinase type II subunit gamma5582Ensembl, GeneID, HGNCUniProt

Patents 13

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-1913626Q13555Espacenet
EP 4641201 A22025-10-2915656Q13555Espacenet
JP 2025529142 A2025-09-04725Q13555Espacenet
US 12371689 B22025-07-29725Q13555Espacenet
JP 2025517969 A2025-06-1215656Q13555Espacenet
JP 2025517970 A2025-06-1213626Q13555Espacenet
JP 2025062604 A2025-04-1410934Q13555Espacenet
JP 2025032204 A2025-03-1125708Q13555Espacenet
EP 4461818 A22024-11-1325708Q13555Espacenet
JP 2023058610 A2023-04-2525708Q13555Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 7392

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
R01NS081248CaMKII Holoenzyme Mechanisms in Opposing Forms of Synaptic Plasticity372,025NIH's project files
R01HL131517Sex-specific arrhythmogenic mechanisms of atrial fibrillation242,025NIH's project files
P01HL141084Multiscale Systems to Elucidate Susceptibility and Cardioprotective Mechanisms in Cardio-oncology212,025NIH's project files
R01HL092097Calmodulin and Regulation of Cardiac Ryanodine Receptor and CaMKII202,025NIH's project files
R01HL142282CaMKII activation and regulation in adult cardiac myocytes202,025NIH's project files
R01NS118786CaMKII in global cerebral ischemia: mechanisms and therapeutic intervention162,025NIH's project files
P30CA068485Cancer Center Support Grant142,025NIH's project files
P30CA016672Cancer Center Support Grant132,025NIH's project files
R01HL136389The Role of Gasdermin-D/Interleukin-1 Nexus in Atrial Arrhythmogenesis122,025NIH's project files
P30CA008748Cancer Center Support Grant112,025NIH's project files

Papers 11344

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42827403PubTator, text miningPubMed
42822756PubTator, text miningPubMed
42818061PubTator, text miningPubMed
42817999PubTator, text miningPubMed
42811813PubTator, text miningPubMed
42808676PubTator, text miningPubMed
42801669PubTator, text miningPubMed
42794727PubTator, text miningPubMed
42777704PubTator, text miningPubMed
42772619PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license